ReP USP - Resultado da busca

Artigo de periodico
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)
Song, Alice Tung Wan ; Benites, Bruno D.; Lima, Carolina Costa; Vargas, Taiani; Marques, Leonardo da Silva ; Fernandes, Juliana C.; Breda, Felipe C.; Wendel, Silvano; Fachini, Roberta; Rizzo, Luiz V.; Kutner, José Mauro; Silva, Vivian Helena Iida Avelino da ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Chevret, Sylvie; Kallas, Esper Georges ; Rocha, Vanderson Geraldo ; Mendrone Júnior, Alfredo ; Rodrigues, Rodrigo do Tocantins Calado de Saloma ; Santis, Gil Cunha De
Source: The Lancet Regional Health. Americas. Unidades: FM, FMRP, ICB
Subject: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONG, Alice Tung Wan; BENITES, Bruno D.; LIMA, Carolina Costa; et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). The Lancet Regional Health. Americas, London, v. 10, p. 1-10, 2022. Disponível em: < https://doi.org/10.1016/j.lana.2022.100216 > DOI: 10.1016/j.lana.2022.100216.
APA
Song, A. T. W., Benites, B. D., Lima, C. C., Vargas, T., Marques, L. da S., Fernandes, J. C., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). The Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216
NLM
Song ATW, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. The Lancet Regional Health. Americas. 2022 ; 10 1-10.Available from: https://doi.org/10.1016/j.lana.2022.100216
Vancouver
Song ATW, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. The Lancet Regional Health. Americas. 2022 ; 10 1-10.Available from: https://doi.org/10.1016/j.lana.2022.100216
Artigo de periodico-dep/entr
Professores da Poli recebem a medalha “Armando de Salles Oliveira” da USP (2021)
González Lima, Raúl ; Zuffo, Marcelo Knörich ; Bonfa, Eloisa Silva Dutra de Oliveira ; Sabino, Ester Cerdeira ; Kallás, Esper Georges ; Saldiva, Paulo Hilário Nascimento
Source: PoliInforma Semanal -Informativo da Escola Politécnica da USP. Trajetórias Politécnicas. Unidades: EP, FM
Subjects: MEDALHAS, CONCESSÃO DE SERVIÇO PÚBLICO, UNIVERSIDADE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZÁLEZ LIMA, Raúl; ZUFFO, Marcelo Knörich; BONFA, Eloisa Silva Dutra de Oliveira; et al. Professores da Poli recebem a medalha “Armando de Salles Oliveira” da USP. PoliInforma Semanal -Informativo da Escola Politécnica da USP. Trajetórias Politécnicas[S.l: s.n.], 2021.
APA
González Lima, R., Zuffo, M. K., Bonfa, E. S. D. de O., Sabino, E. C., Kallás, E. G., & Saldiva, P. H. N. (2021). Professores da Poli recebem a medalha “Armando de Salles Oliveira” da USP. PoliInforma Semanal -Informativo da Escola Politécnica da USP. Trajetórias Politécnicas. Sao Paulo.
NLM
González Lima R, Zuffo MK, Bonfa ESD de O, Sabino EC, Kallás EG, Saldiva PHN. Professores da Poli recebem a medalha “Armando de Salles Oliveira” da USP. PoliInforma Semanal -Informativo da Escola Politécnica da USP. Trajetórias Politécnicas. 2021 ;
Vancouver
González Lima R, Zuffo MK, Bonfa ESD de O, Sabino EC, Kallás EG, Saldiva PHN. Professores da Poli recebem a medalha “Armando de Salles Oliveira” da USP. PoliInforma Semanal -Informativo da Escola Politécnica da USP. Trajetórias Politécnicas. 2021 ;
Trabalho de evento-resumo periodico
Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) (2021)
Bonifacio, L.; Souza, H.; Louzada Júnior, Paulo; Fonseca, Benedito Antonio Lopes da; Lopes, R.; Kallas, Esper Georges ; Bellíssimo-Rodrigues, Fernando; Tojal, A.; Ramacciotti, E.; Agati, L.; Vilar, F.
Source: Antimicrobial Resistance & Infection Control. Conference title: International Conference on Prevention & Infection Control (ICPIC 2021). Unidades: FMRP, FM
Subjects: COVID-19, PACIENTES INTERNADOS, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS, CITOCINAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACIO, L.; SOUZA, H.; LOUZADA JÚNIOR, Paulo; et al. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control[S.l: s.n.], 2021.Disponível em: .
APA
Bonifacio, L., Souza, H., Louzada Júnior, P., Fonseca, B. A. L. da, Lopes, R., Kallas, E. G., et al. (2021). Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London. Recuperado de https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
NLM
Bonifacio L, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F, Tojal A, Ramacciotti E, Agati L, Vilar F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Vancouver
Bonifacio L, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F, Tojal A, Ramacciotti E, Agati L, Vilar F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Artigo de periodico
COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes (2021)
Yokoyama, Ana Paula Hitomi ; Wendel, Silvano ; Bub, Carolina Bonet ; Fachini, Roberta M.; Dametto, Ana Paula F.; Blumm, Fernando; Dutra, Valeria F. ; Candelaria, Gabriela T. P. ; Sakashita, Araci M.; Machado, Rafael Rahal Guaragna ; Achkar, Ruth; Assunção, Murillo Santucci Cesar ; Scuracchio, Patrícia; Nudelman, Victor; Pastore, Laerte; Pinho, João R. R.; Ben, Mirian Dal; Kalil Filho, Roberto ; Marra, Alexandre R.; Amano, Mariane T. ; Kallás, Esper Georges ; Helito, Alfredo Salim; Carvalho, Carlos Roberto Ribeiro De ; Araujo, Danielle Bastos ; Durigon, Edison Luiz ; Camargo, Anamaria Aranha ; Rizzo, Luiz V. ; Reis, Luiz F. L. ; Kutner, José Mauro ; Wendel, Rita Fontão; Hamerschlak, Nelson
Source: Transfusion. Unidades: ICB, FM
Subjects: PLASMA, ANTICORPOS, ESTUDOS DE COORTES, PACIENTES, UNIDADES DE TERAPIA INTENSIVA, MICROBIOLOGIA, COVID-19, TRANSFUSÃO DE SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOKOYAMA, Ana Paula Hitomi; WENDEL, Silvano; BUB, Carolina Bonet; et al. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, Hoboken, p. 1-12, 2021. Disponível em: < https://doi.org/10.1111/trf.16573 > DOI: 10.1111/trf.16573.
APA
Yokoyama, A. P. H., Wendel, S., Bub, C. B., Fachini, R. M., Dametto, A. P. F., Blumm, F., et al. (2021). COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, 1-12. doi:10.1111/trf.16573
NLM
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM, Wendel RF, Hamerschlak N. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.Available from: https://doi.org/10.1111/trf.16573
Vancouver
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM, Wendel RF, Hamerschlak N. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.Available from: https://doi.org/10.1111/trf.16573
Artigo de periodico
Air pollution impairs recovery and tissue remodeling in a murine model of acute lung injury (2020)
Costa, Natalia de Souza Xavier; Ribeiro Junior, Gabriel; Alemany, Adair Aparecida dos Santos; Belotti, Luciano; Schalch, Alexandre Santos; Cavalcante, Marcela Frota; Kallas, Esper Georges ; Saldiva, Paulo Hilário Nascimento ; Dolhnikoff, Marisa ; Silva, Luiz Fernando Ferraz da
Source: Scientific reports. Unidade: FM
Subjects: POLUIÇÃO ATMOSFÉRICA, PULMÃO, PNEUMOPATIAS, INFLAMAÇÃO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Natalia de Souza Xavier; RIBEIRO JUNIOR, Gabriel; ALEMANY, Adair Aparecida dos Santos; et al. Air pollution impairs recovery and tissue remodeling in a murine model of acute lung injury. Scientific reports, Berlin, v. 10, n. 1, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/38374 > DOI: 10.1038/s41598-020-72130-3.
APA
Costa, N. de S. X., Ribeiro Junior, G., Alemany, A. A. dos S., Belotti, L., Schalch, A. S., Cavalcante, M. F., et al. (2020). Air pollution impairs recovery and tissue remodeling in a murine model of acute lung injury. Scientific reports, 10( 1). doi:10.1038/s41598-020-72130-3
NLM
Costa N de SX, Ribeiro Junior G, Alemany AA dos S, Belotti L, Schalch AS, Cavalcante MF, Kallas EG, Saldiva PHN, Dolhnikoff M, Silva LFF da. Air pollution impairs recovery and tissue remodeling in a murine model of acute lung injury [Internet]. Scientific reports. 2020 ; 10( 1):Available from: https://observatorio.fm.usp.br/handle/OPI/38374
Vancouver
Costa N de SX, Ribeiro Junior G, Alemany AA dos S, Belotti L, Schalch AS, Cavalcante MF, Kallas EG, Saldiva PHN, Dolhnikoff M, Silva LFF da. Air pollution impairs recovery and tissue remodeling in a murine model of acute lung injury [Internet]. Scientific reports. 2020 ; 10( 1):Available from: https://observatorio.fm.usp.br/handle/OPI/38374
Artigo de periodico
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program (2020)
Wendel, Silvano ; Hamerschlak, Nelson ; Scuracchio, Patricia; Amaral, Marcelo; Ben, Mirian Dal; Araujo, Danielle Bastos ; Soares, Camila Pereira ; Camargo, Anamaria ; Kallás, Esper Georges ; Durigon, Edison Luiz ; Reis, Luiz Fernando ; Rizzo, Luiz Vicente ; Kutner, José Mauro ; Machado, Rafael Rahal Guaragna ; Wendel, Rita Fontão; Bub, Carolina ; Fachini, Roberta; Yokoyama, Ana ; Candelaria, Gabriela ; Sakashita, Araci ; Achkar, Ruth
Source: Transfusion. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, IMUNOTERAPIA, PLASMA, ANTICORPOS, TRIAGEM, REAÇÃO EM CADEIA POR POLIMERASE, ADJUVANTES IMUNOLÓGICOS, IMUNOGLOBULINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano; HAMERSCHLAK, Nelson; SCURACCHIO, Patricia; et al. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, Hoboken, p. 1-4, 2020. Disponível em: < https://doi.org/10.1111/trf.16065 > DOI: 10.1111/trf.16065.
APA
Wendel, S., Hamerschlak, N., Scuracchio, P., Amaral, M., Ben, M. D., Araujo, D. B., et al. (2020). Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, 1-4. doi:10.1111/trf.16065
NLM
Wendel S, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.Available from: https://doi.org/10.1111/trf.16065
Vancouver
Wendel S, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.Available from: https://doi.org/10.1111/trf.16065
Artigo de periodico
HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals (2020)
Leda, Ana Rachel; Hunter, James; Oliveira, Ursula Castro de; Azevedo, Inacio Junqueira de; Kallás, Esper Georges ; Sucupira, Maria Cecilia Araripe; Diaz, Ricardo Sobhie
Source: Virology. Unidade: FM
Subjects: TROPISMO, CARGA VIRAL, HIV, VARIAÇÃO GENÉTICA, AVANÇO DA DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEDA, Ana Rachel; HUNTER, James; OLIVEIRA, Ursula Castro de; et al. HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals. Virology, San Diego, v. 541, p. 13-24, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/35970 > DOI: 10.1016/j.virol.2019.11.006.
APA
Leda, A. R., Hunter, J., Oliveira, U. C. de, Azevedo, I. J. de, Kallás, E. G., Sucupira, M. C. A., & Diaz, R. S. (2020). HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals. Virology, 541, 13-24. doi:10.1016/j.virol.2019.11.006
NLM
Leda AR, Hunter J, Oliveira UC de, Azevedo IJ de, Kallás EG, Sucupira MCA, Diaz RS. HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals [Internet]. Virology. 2020 ; 541 13-24.Available from: https://observatorio.fm.usp.br/handle/OPI/35970
Vancouver
Leda AR, Hunter J, Oliveira UC de, Azevedo IJ de, Kallás EG, Sucupira MCA, Diaz RS. HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals [Internet]. Virology. 2020 ; 541 13-24.Available from: https://observatorio.fm.usp.br/handle/OPI/35970
Artigo de periodico
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial (2020)
Kallás, Esper Georges ; Precioso, Alexander Roberto; Palacios, Ricardo; Thome, Beatriz; Braga, Patricia Emilia; Vanni, Tazio; Campos, Lucia M. A; Ferrari, Lilian; Mondini, Gabriella; Kalil Filho, Jorge Elias
Source: Lancet infectious diseases. Unidade: FM
Subjects: ANTICORPOS, IMUNOGENICIDADE DA VACINA, MÉTODO DUPLO-CEGO, VÍRUS DA DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLÁS, Esper Georges; PRECIOSO, Alexander Roberto; PALACIOS, Ricardo; et al. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet infectious diseases, Oxford, v. 20, n. 7, p. 839-850, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/36870 > DOI: 10.1016/S1473-3099(20)30023-2.
APA
Kallás, E. G., Precioso, A. R., Palacios, R., Thome, B., Braga, P. E., Vanni, T., et al. (2020). Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet infectious diseases, 20( 7), 839-850. doi:10.1016/S1473-3099(20)30023-2
NLM
Kallás EG, Precioso AR, Palacios R, Thome B, Braga PE, Vanni T, Campos LMA, Ferrari L, Mondini G, Kalil Filho JE. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial [Internet]. Lancet infectious diseases. 2020 ; 20( 7): 839-850.Available from: https://observatorio.fm.usp.br/handle/OPI/36870
Vancouver
Kallás EG, Precioso AR, Palacios R, Thome B, Braga PE, Vanni T, Campos LMA, Ferrari L, Mondini G, Kalil Filho JE. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial [Internet]. Lancet infectious diseases. 2020 ; 20( 7): 839-850.Available from: https://observatorio.fm.usp.br/handle/OPI/36870
Artigo de periodico
Immune effects ofLactobacillus caseiShirota in treated HIV-infected patients with poor CD4+T-cell recovery (2020)
Tenore, Simone de Barros; Silva, Vivian Helena Iida Avelino da ; Costa, Priscilla Ramos; Franco, Lucas M; Sabino, Ester Cerdeira ; Kalil Filho, Jorge Elias ; Cerqueira, Natalia Barros; Nakagawa, Zelinda; Kallás, Esper Georges
Source: Aids. Unidade: FM
Subjects: PROBIÓTICOS, LACTOBACILLUS, HIV, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TENORE, Simone de Barros; SILVA, Vivian Helena Iida Avelino da; COSTA, Priscilla Ramos; et al. Immune effects ofLactobacillus caseiShirota in treated HIV-infected patients with poor CD4+T-cell recovery. Aids, Philadelphia, v. 34, n. 3, p. 381-389, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/36865 > DOI: 10.1097/QAD.0000000000002420.
APA
Tenore, S. de B., Silva, V. H. I. A. da, Costa, P. R., Franco, L. M., Sabino, E. C., Kalil Filho, J. E., et al. (2020). Immune effects ofLactobacillus caseiShirota in treated HIV-infected patients with poor CD4+T-cell recovery. Aids, 34( 3), 381-389. doi:10.1097/QAD.0000000000002420
NLM
Tenore S de B, Silva VHIA da, Costa PR, Franco LM, Sabino EC, Kalil Filho JE, Cerqueira NB, Nakagawa Z, Kallás EG. Immune effects ofLactobacillus caseiShirota in treated HIV-infected patients with poor CD4+T-cell recovery [Internet]. Aids. 2020 ; 34( 3): 381-389.Available from: https://observatorio.fm.usp.br/handle/OPI/36865
Vancouver
Tenore S de B, Silva VHIA da, Costa PR, Franco LM, Sabino EC, Kalil Filho JE, Cerqueira NB, Nakagawa Z, Kallás EG. Immune effects ofLactobacillus caseiShirota in treated HIV-infected patients with poor CD4+T-cell recovery [Internet]. Aids. 2020 ; 34( 3): 381-389.Available from: https://observatorio.fm.usp.br/handle/OPI/36865
Artigo de periodico-carta/editorial
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial (2020)
Palacios, Ricardo; Patino, Elizabeth Gonzalez; Piorelli, Roberta de Oliveira; Conde, Monica Tilli Reis Pessoa; Batista, Ana Paula; Zeng, Gang; Xin, Qianqian; Kallas, Esper Georges ; Flores, Jorge; Ockenhouse, Christian F
Source: Trials. Unidade: FM
Subjects: COVID-19, PANDEMIAS, VACINAS, VACINAÇÃO, ENVELHECIMENTO, INCIDÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALACIOS, Ricardo; PATINO, Elizabeth Gonzalez; PIORELLI, Roberta de Oliveira; et al. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials[S.l: s.n.], 2020.Disponível em: DOI: 10.1186/s13063-020-04775-4.
APA
Palacios, R., Patino, E. G., Piorelli, R. de O., Conde, M. T. R. P., Batista, A. P., Zeng, G., et al. (2020). Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials. London. doi:10.1186/s13063-020-04775-4
NLM
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):Available from: https://observatorio.fm.usp.br/handle/OPI/38369
Vancouver
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):Available from: https://observatorio.fm.usp.br/handle/OPI/38369
Artigo de periodico
Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018 (2019)
Delatorre, Edson; Abreu, Filipe Vieira Santos de; Ribeiro, Ieda Pereira; Gomez, Mariela Martinez; Santos, Alexandre Araujo Cunha dos; Ferreira-de-brito, Anielly; Neves, Maycon Sebastiao Alberto Santos; Bonelly, Iule; Miranda, Rafaella Moraes de; Kallás, Esper Georges
Source: Frontiers in microbiology. Unidade: FM
Subjects: FEBRE AMARELA, SURTOS DE DOENÇAS, GENÔMICA, BRASIL, REGIÃO CENTRO OESTE, REGIÃO SUDESTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELATORRE, Edson; ABREU, Filipe Vieira Santos de; RIBEIRO, Ieda Pereira; et al. Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018. Frontiers in microbiology, Lausanne, v. 10, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/32429 > DOI: 10.3389/fmicb.2019.01079.
APA
Delatorre, E., Abreu, F. V. S. de, Ribeiro, I. P., Gomez, M. M., Santos, A. A. C. dos, Ferreira-de-brito, A., et al. (2019). Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018. Frontiers in microbiology, 10. doi:10.3389/fmicb.2019.01079
NLM
Delatorre E, Abreu FVS de, Ribeiro IP, Gomez MM, Santos AAC dos, Ferreira-de-brito A, Neves MSAS, Bonelly I, Miranda RM de, Kallás EG. Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018 [Internet]. Frontiers in microbiology. 2019 ; 10Available from: http://observatorio.fm.usp.br/handle/OPI/32429
Vancouver
Delatorre E, Abreu FVS de, Ribeiro IP, Gomez MM, Santos AAC dos, Ferreira-de-brito A, Neves MSAS, Bonelly I, Miranda RM de, Kallás EG. Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018 [Internet]. Frontiers in microbiology. 2019 ; 10Available from: http://observatorio.fm.usp.br/handle/OPI/32429
Artigo de periodico
Predictors of mortality in patients with yellow fever: an observational cohort study (2019)
Kallás, Esper Georges; Zanella, Luiz Gonzaga F. A. B. D'Elia; V, Carlos Henrique Moreira; Buccheri, Renata; Diniz, Gabriela B. F; Castineiras, Anna Carla P; Costa, Priscilla R; Dias, Juliana Z. C; Sabino, Ester Cerdeira ; Silva, Vivian Helena Iida Avelino da
Source: Lancet infectious diseases. Unidade: FM
Subjects: FEBRE AMARELA, HOSPITAIS, INFECÇÕES POR VÍRUS DE RNA, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLÁS, Esper Georges; ZANELLA, Luiz Gonzaga F. A. B. D'Elia; V, Carlos Henrique Moreira; et al. Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet infectious diseases, Oxford, v. 19, n. 7, p. 750-758, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/33102 > DOI: 10.1016/S1473-3099(19)30125-2.
APA
Kallás, E. G., Zanella, L. G. F. A. B. D. 'E., V, C. H. M., Buccheri, R., Diniz, G. B. F., Castineiras, A. C. P., et al. (2019). Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet infectious diseases, 19( 7), 750-758. doi:10.1016/S1473-3099(19)30125-2
NLM
Kallás EG, Zanella LGFABD'E, V CHM, Buccheri R, Diniz GBF, Castineiras ACP, Costa PR, Dias JZC, Sabino EC, Silva VHIA da. Predictors of mortality in patients with yellow fever: an observational cohort study [Internet]. Lancet infectious diseases. 2019 ; 19( 7): 750-758.Available from: http://observatorio.fm.usp.br/handle/OPI/33102
Vancouver
Kallás EG, Zanella LGFABD'E, V CHM, Buccheri R, Diniz GBF, Castineiras ACP, Costa PR, Dias JZC, Sabino EC, Silva VHIA da. Predictors of mortality in patients with yellow fever: an observational cohort study [Internet]. Lancet infectious diseases. 2019 ; 19( 7): 750-758.Available from: http://observatorio.fm.usp.br/handle/OPI/33102
Artigo de periodico
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study (2019)
Marins, Luana M. S; Torres, Thiago S; Leite, Iuri da C; Moreira, Ronaldo I; Luz, Paula M; Hoagland, Brenda; Kallas, Esper Georges ; Madruga, Jose Valdez; Liu, Albert Y; Anderson, Peter L
Source: PLOS ONE. Unidade: FM
Subjects: ADESÃO À MEDICAÇÃO, COOPERAÇÃO DO PACIENTE, DOENÇAS SEXUALMENTE TRANSMISSÍVEIS, HOMOSSEXUALIDADE, TRANSEXUALIDADE, COMPORTAMENTO DE RISCO, ANTI-HIV, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARINS, Luana M. S; TORRES, Thiago S; LEITE, Iuri da C; et al. Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study. PLOS ONE, San Francisco, v. 14, n. 8, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34421 > DOI: 10.1371/journal.pone.0221281.
APA
Marins, L. M. S., Torres, T. S., Leite, I. da C., Moreira, R. I., Luz, P. M., Hoagland, B., et al. (2019). Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study. PLOS ONE, 14( 8). doi:10.1371/journal.pone.0221281
NLM
Marins LMS, Torres TS, Leite I da C, Moreira RI, Luz PM, Hoagland B, Kallas EG, Madruga JV, Liu AY, Anderson PL. Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study [Internet]. PLOS ONE. 2019 ; 14( 8):Available from: http://observatorio.fm.usp.br/handle/OPI/34421
Vancouver
Marins LMS, Torres TS, Leite I da C, Moreira RI, Luz PM, Hoagland B, Kallas EG, Madruga JV, Liu AY, Anderson PL. Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study [Internet]. PLOS ONE. 2019 ; 14( 8):Available from: http://observatorio.fm.usp.br/handle/OPI/34421
Artigo de periodico
Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic (2019)
Hanajiri, Ryo; Sani, Gelina M; Hanley, Patrick J; Silveira, Cassia G; Kallás, Esper Georges ; Keller, Michael D; Bollard, Catherine M
Source: Cytotherapy. Unidade: FM
Subjects: LINFÓCITOS T, ZIKA VÍRUS, CORDÃO UMBILICAL, IMUNOTERAPIA, TESTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HANAJIRI, Ryo; SANI, Gelina M; HANLEY, Patrick J; et al. Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic. Cytotherapy, Oxford, v. 21, n. 8, p. 840-855, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34033 > DOI: 10.1016/j.jcyt.2019.06.008.
APA
Hanajiri, R., Sani, G. M., Hanley, P. J., Silveira, C. G., Kallás, E. G., Keller, M. D., & Bollard, C. M. (2019). Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic. Cytotherapy, 21( 8), 840-855. doi:10.1016/j.jcyt.2019.06.008
NLM
Hanajiri R, Sani GM, Hanley PJ, Silveira CG, Kallás EG, Keller MD, Bollard CM. Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic [Internet]. Cytotherapy. 2019 ; 21( 8): 840-855.Available from: http://observatorio.fm.usp.br/handle/OPI/34033
Vancouver
Hanajiri R, Sani GM, Hanley PJ, Silveira CG, Kallás EG, Keller MD, Bollard CM. Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic [Internet]. Cytotherapy. 2019 ; 21( 8): 840-855.Available from: http://observatorio.fm.usp.br/handle/OPI/34033
Artigo de periodico-carta/editorial
Managing severe yellow fever in the intensive care [Editorial]: lessons learnt from Brazil (2019)
Kallas, Esper Georges ; Wilder-smith, A
Source: Journal of travel medicine. Unidade: FM
Subjects: FEBRE AMARELA, UNIDADES DE TERAPIA INTENSIVA, VACINAÇÃO, TRANSMISSÃO DE DOENÇAS, SURTOS DE DOENÇAS, BRASIL, ANGOLA, CHINA, ESTADOS UNIDOS, EUROPA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLAS, Esper Georges; WILDER-SMITH, A. Managing severe yellow fever in the intensive care [Editorial]: lessons learnt from Brazil. Journal of travel medicine[S.l: s.n.], 2019.Disponível em: DOI: 10.1093/jtm/taz043.
APA
Kallas, E. G., & Wilder-smith, A. (2019). Managing severe yellow fever in the intensive care [Editorial]: lessons learnt from Brazil. Journal of travel medicine. Cary. doi:10.1093/jtm/taz043
NLM
Kallas EG, Wilder-smith A. Managing severe yellow fever in the intensive care [Editorial]: lessons learnt from Brazil [Internet]. Journal of travel medicine. 2019 ; 26( 5):Available from: http://observatorio.fm.usp.br/handle/OPI/34426
Vancouver
Kallas EG, Wilder-smith A. Managing severe yellow fever in the intensive care [Editorial]: lessons learnt from Brazil [Internet]. Journal of travel medicine. 2019 ; 26( 5):Available from: http://observatorio.fm.usp.br/handle/OPI/34426
Artigo de periodico
A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results (2019)
Pilcher, Christopher D; Porco, Travis C; Facente, Shelley N; Grebe, Eduard; Delaney, Kevin P; Masciotra, Silvina; Kassanjee, Reshma; Busch, Michael P; Murphy, Gary; Kallás, Esper Georges
Source: Aids. Unidade: FM
Subjects: INFECÇÕES POR HIV, TÉCNICAS DE DIAGNÓSTICO E PROCEDIMENTOS, ESTIMATIVA DE TEMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PILCHER, Christopher D; PORCO, Travis C; FACENTE, Shelley N; et al. A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results. Aids, Philadelphia, v. 33, n. 7, p. 1231-1240, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34019 > DOI: 10.1097/QAD.0000000000002190.
APA
Pilcher, C. D., Porco, T. C., Facente, S. N., Grebe, E., Delaney, K. P., Masciotra, S., et al. (2019). A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results. Aids, 33( 7), 1231-1240. doi:10.1097/QAD.0000000000002190
NLM
Pilcher CD, Porco TC, Facente SN, Grebe E, Delaney KP, Masciotra S, Kassanjee R, Busch MP, Murphy G, Kallás EG. A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results [Internet]. Aids. 2019 ; 33( 7): 1231-1240.Available from: http://observatorio.fm.usp.br/handle/OPI/34019
Vancouver
Pilcher CD, Porco TC, Facente SN, Grebe E, Delaney KP, Masciotra S, Kassanjee R, Busch MP, Murphy G, Kallás EG. A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results [Internet]. Aids. 2019 ; 33( 7): 1231-1240.Available from: http://observatorio.fm.usp.br/handle/OPI/34019
Artigo de periodico
Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial (2019)
Kallas, Esper Georges ; Grunenberg, Nicole A; Yu, Chenchen; Manso, Bryce; Pantaleo, Giuseppe; Casapia, Martin; Baden, Lindsey R; Valencia, Javier; Sobieszczyk, Magdalena; Hong Van Tieu
Source: Science translational medicine. Unidade: FM
Subjects: VACINAS VIRAIS, ANTI-HIV, LINFÓCITOS T, IMUNOGENICIDADE DA VACINA, ENSAIO LITERÁRIO, MÉTODO DUPLO-CEGO, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLAS, Esper Georges; GRUNENBERG, Nicole A; YU, Chenchen; et al. Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Science translational medicine, Washington, v. 11, n. 519, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34431 > DOI: 10.1126/scitranslmed.aaw1673.
APA
Kallas, E. G., Grunenberg, N. A., Yu, C., Manso, B., Pantaleo, G., Casapia, M., et al. (2019). Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Science translational medicine, 11( 519). doi:10.1126/scitranslmed.aaw1673
NLM
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Hong Van Tieu. Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial [Internet]. Science translational medicine. 2019 ; 11( 519):Available from: http://observatorio.fm.usp.br/handle/OPI/34431
Vancouver
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Hong Van Tieu. Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial [Internet]. Science translational medicine. 2019 ; 11( 519):Available from: http://observatorio.fm.usp.br/handle/OPI/34431
Artigo de periodico
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance (2019)
Sempa, Joseph B; Welte, Alex; Busch, Michael P; Hall, Jake; Hampton, Dylan; Facente, Shelley N; Keating, Sheila M; Marson, Kara; Parkin, Neil; Kallas, Esper Georges
Source: PLOS ONE. Unidade: FM
Subjects: INCIDÊNCIA, ANTÍGENOS DE VÍRUS, HIV, SURTOS DE DOENÇAS, VIGILÂNCIA DA POPULAÇÃO, CARGA VIRAL, INFECÇÕES POR HIV, QUÊNIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEMPA, Joseph B; WELTE, Alex; BUSCH, Michael P; et al. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance. PLOS ONE, San Francisco, v. 14, n. 7, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34422 > DOI: 10.1371/journal.pone.0220345.
APA
Sempa, J. B., Welte, A., Busch, M. P., Hall, J., Hampton, D., Facente, S. N., et al. (2019). Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance. PLOS ONE, 14( 7). doi:10.1371/journal.pone.0220345
NLM
Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Kallas EG. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance [Internet]. PLOS ONE. 2019 ; 14( 7):Available from: http://observatorio.fm.usp.br/handle/OPI/34422
Vancouver
Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Kallas EG. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance [Internet]. PLOS ONE. 2019 ; 14( 7):Available from: http://observatorio.fm.usp.br/handle/OPI/34422
Artigo de periodico
Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika Virus-specific CD8(+) T Cells (2018)
Grifoni, Alba; Costa-Ramos, Priscilla; Pham, John; Tian, Yuan; Rosales, Sandy L.; Seumois, Gregory; Sidney, John; Silva, Aruna D. de; Premkumar, Lakshmanane; Kallás, Esper Georges
Source: Journal of immunology. Unidade: FM
Subjects: ZIKA VÍRUS, ANTÍGENOS DE VÍRUS, IMUNOLOGIA CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRIFONI, Alba; COSTA-RAMOS, Priscilla; PHAM, John; et al. Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika Virus-specific CD8(+) T Cells. Journal of immunology, Bethesda, v. 201, n. 12, p. 3487-3491, 2018. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/29839 > DOI: 10.4049/jimmunol.1801090.
APA
Grifoni, A., Costa-Ramos, P., Pham, J., Tian, Y., Rosales, S. L., Seumois, G., et al. (2018). Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika Virus-specific CD8(+) T Cells. Journal of immunology, 201( 12), 3487-3491. doi:10.4049/jimmunol.1801090
NLM
Grifoni A, Costa-Ramos P, Pham J, Tian Y, Rosales SL, Seumois G, Sidney J, Silva AD de, Premkumar L, Kallás EG. Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika Virus-specific CD8(+) T Cells [Internet]. Journal of immunology. 2018 ; 201( 12): 3487-3491.Available from: http://observatorio.fm.usp.br/handle/OPI/29839
Vancouver
Grifoni A, Costa-Ramos P, Pham J, Tian Y, Rosales SL, Seumois G, Sidney J, Silva AD de, Premkumar L, Kallás EG. Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika Virus-specific CD8(+) T Cells [Internet]. Journal of immunology. 2018 ; 201( 12): 3487-3491.Available from: http://observatorio.fm.usp.br/handle/OPI/29839
Artigo de periodico
Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques (2018)
Magnani, Diogo M.; Kallas, Esper G.
Source: Nature communications. Unidade: FM
Subjects: ZIKA VÍRUS, PRIMATAS, GRAVIDEZ, MORTE FETAL EM ANIMAL, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGNANI, Diogo M.; KALLAS, Esper G. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. Nature communications, London, v. 9, 2018. Disponível em: < http://dx.doi.org/10.1038/s41467-018-04056-4 > DOI: 10.1038/s41467-018-04056-4.
APA
Magnani, D. M., & Kallas, E. G. (2018). Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. Nature communications, 9. doi:10.1038/s41467-018-04056-4
NLM
Magnani DM, Kallas EG. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques [Internet]. Nature communications. 2018 ; 9Available from: http://dx.doi.org/10.1038/s41467-018-04056-4
Vancouver
Magnani DM, Kallas EG. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques [Internet]. Nature communications. 2018 ; 9Available from: http://dx.doi.org/10.1038/s41467-018-04056-4

USP Schools

ReP

Filters

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration